Clinical Trial Detail

NCT ID NCT03317119
Title Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors City of Hope Medical Center
Indications

rectum cancer

colon cancer

Therapies

Trametinib + Trifluridine-tipiracil hydrochloride

Age Groups: adult senior

Additional content available in CKB BOOST